-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Genomic History of the Solomon Islands
Study
EGAS00001006116
-
Multi-omics integration reveals only minor long-term molecular and functional sequelae in immune cells of individuals recovered from COVID-19
Study
EGAS00001005529
-
The endometrial transcription landscape of MRKH syndrome
Study
EGAS00001004601
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Study
EGAS00001004614
-
Understanding_hematopoietic_stem_cell_mobilization_and_engraftment_
Study
EGAS00001004620
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
DLBCL NGS Genomic Datasets of non-China cohort from Phoenix Clinical Trial
Study
EGAS00001005554
-
Targeting AXL Kinase Uniquely Sensitizes Therapy-Insensitive Leukemic Stem and Progenitor Cells to Venetoclax Treatment in Acute Myeloid Leukemia
Study
EGAS00001004663
-
International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia
Study
EGAS00001004682
-
Somatic L1 retrotranspositions in normal human cells
Study
EGAS00001006213
-
Allele-specific expression of GATA2 due to epigenetic dysregulation in double mutated CEBPA AML
Study
EGAS00001004684
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232
-
Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer
Study
EGAS00001003367
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma
Study
EGAS00001004709
-
STAT5 is a therapeutically targetable vulnerability in cutaneous T-cell lymphoma
Study
EGAS00001004719
-
Multi-omic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target
Study
EGAS00001005647
-
Exome sequencing
Study
EGAS00001005761
-
Small variants in mtDNA Canary Islands - WGS Oxford Nanopore Technologies (ITER)
Study
EGAS00001005677
-
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements
Study
EGAS00001003415
-
Neuroblastoma tumor heterogeneity and cell plasticity (from PDX and cell lines)
Study
EGAS00001004781
-
Genomics-based personalized oncology in cancer of unknown primary (CUP, project H021)
Study
EGAS00001004786
-
Molecular landscape of blastic plasmacytoid dendritic cell neoplasm
Study
EGAS00001006166
-
Study the genetic susceptibility of esophagus squamous cell carcinomas (ESCC) in high-risk area Henan Chinese
Study
EGAS00001003423
-
Genomic_profiling_of_B_other_Adult_ALL_RNA
Study
EGAS00001003428
-
Genomic analysis of a hypermutated gliosarcoma
Study
EGAS00001004864
-
Targeted de-methylation of the FOXP3-TSDR
Study
EGAS00001004867
-
Proteogenomics of chronic lymphocytic leukemia
Study
EGAS00001005746
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Study
EGAS00001003430
-
Functional and genomic heterogeneity of long-term self-renewing compartment as the origin of treatment resistance in pancreatic tumors
Study
EGAS00001003442
-
Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients
Study
EGAS00001006198
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
Identification of the dismal subtype of B-ALL with dysregulation of CDX2 and UBTF
Study
EGAS00001005863
-
Defining structural variation associated with breast cancer susceptibility by long-read genome sequencing
Study
EGAS00001005872
-
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
Study
EGAS00001006205
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Extensive patient-to-patient single nuclei transcriptome heterogeneity in pheochromocytomas and paragangliomas
Study
EGAS00001006230
-
The European MAPPYACTS trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
Study
EGAS00001005935
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Single cell genomic variation induced by mutational processes in cancer
Study
EGAS00001006343
-
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs drug target discovery in ankylosing spondylitis
Study
EGAS00001006233
-
Human genome-wide variations in the Massim region
Study
EGAS00001006010
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (ChIP-seq)
Study
EGAS00001006017
-
EXCEED Study
Study
EGAS00001003499
-
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
Study
EGAS00001006422
-
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Study
EGAS00001006059